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Summary
Purpose—Few studies have found differences in rates of epilepsy by race or ethnicity although 
previous reports indicate strong links between epilepsy and socioeconomic indicators. We 
investigated social and demographic factors as they relate to prevalence and incidence of epilepsy 
in Washington, DC, a culturally diverse area.
Methods—Probability-based sampling was used to select 20,000 DC households that were 
mailed an epilepsy screening survey. Demographic and epilepsy data were obtained on all 
household members. Screened individuals with a history of epilepsy or seizure disorder were sent 
a case survey asking more detailed questions about seizures and treatment which were used to 
verify case status using the standard case definition. Survey data were weighted to match 
characteristics of DC residents. Lifetime and active prevalence and incidence of epilepsy were 
estimated using weighted data and appropriate survey procedures in SAS.
Key Findings—Overall survey response rate was 36.6%. 208 cases of epilepsy were identified 
during screening and 14% with a case survey were considered false positive. Using the verified 
dataset, lifetime prevalence was 1.53% overall; 0.77% in Whites, 2.13% in Blacks, 3.4% in those 
with less than a high school diploma, and 2.27% in those with household income less than 
$30,000. Overall prevalence of active epilepsy was 0.79% and followed similar subgroup 
comparisons as lifetime prevalence. Age-adjusted lifetime and active epilepsy from multivariate 
analyses demonstrated significantly higher rates for Blacks compared to Whites and for those not 
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completing high school compared to those that attended graduate school. The overall incidence of 
epilepsy was 71 per 100,000 persons. Adults with active epilepsy were significantly less likely to 
live alone than those without epilepsy (36.0% versus 46.1%). Residents of DC for less than four 
years had the lowest prevalence and incidence of all subgroups indicating a possible healthy 
mover effect.
Significance—Our study is the first to provide region-specific estimates and profiles of the 
epilepsy population in DC which can help inform policy makers and healthcare providers on 
where to better target resources to improve the health and outcomes of people with epilepsy and 
their families.
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Introduction
General surveys measuring self-reported epilepsy occurrence among U.S. adult populations 
have yielded estimates of lifetime prevalence ranging from 1.2 to 2.9%, and estimates of 
active or point prevalence ranging from 0.8 to 1.6% (Konda et al., 2009; Kobau et al., 2008; 
Kobau et al., 2006; Ottman et al., 2011). These variations may be due to differences in study 
population demographics and survey methodology. From population-based studies in 
developed countries, which include additional methods to confirm clinical diagnoses of 
epilepsy, estimates of epilepsy prevalence across all ages range from 0.4% to 0.9% and in 
children range from 0.4% to 0.5% (Hirtz et al., 2007). The median estimate of age-adjusted 
epilepsy incidence among such studies is 48 per 100,000 (Hirtz et al., 2007).
In most population-based surveys, prevalence has been estimated using a single screening 
question that asks about the history of a diagnosis of epilepsy or a seizure disorder. 
However, a study that involved additional self-reported information about seizures and 
treatment found that 18.5% of reports from a single screening question were false positive 
(Kelvin et al., 2007). When medical records were used as the gold standard for a diagnosis 
of epilepsy compared to a self-report, the false positive rate from a single screening question 
rose to 23.8% (Ottman et al., 2010).
With few exceptions, U.S. studies have found no significant differences in rates of epilepsy 
by race or ethnicity (Burneo et al., 2009; Ottman et al., 2011; Kelvin et al., 2007; Kobau et 
al., 2006; Kobau et al., 2008; Haerer et al., 1986). However, there are previous reports of 
strong links between epilepsy and lower educational attainment and income (Elliott et al., 
2009; Kobau et al., 2007; Elliott et al., 2008; Konda et al., 2009; Kobau et al., 2006; Ottman 
et al., 2011; Ferguson et al., 2008, Geerts et al., 2011, Sillanpaa, 2004). While education is 
highly correlated with income and expected to produce analogous results, it also involves 
cognitive aspects that can impact recognition of and self-care for epilepsy, as well as the 
ability to live independently.
The Washington DC Health Study (DCHS) was initiated to estimate the incidence and 
prevalence of epilepsy among underrepresented groups to help guide policy makers and 
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health care organizations in understanding potential disparities in access to care. The District 
of Columbia (DC) was chosen as the study site because of its rich cultural, racial and 
socioeconomic diversity. According to 2009 census data, DC includes a high proportion of 
non-Hispanic Blacks (52.7%) compared to the national estimate of 12.1%. Although the 
median household income for DC is higher than the country as a whole, the number of 
families living below poverty level is also higher than the national average (14.6% versus 
10.5%). In addition, compared to national averages, DC has more adult residents that live 
alone (46.6% versus 27.4%) and are highly educated (28.0% versus 10.3%). We sought to 
investigate these factors and other demographic indicators as they relate to the prevalence 
and incidence of epilepsy.
METHODS
Sampling Frame
Address Based Sampling (ABS) was used to reach a representative sample of 20,000 
households in DC. This method has gained recent popularity because of evolving problems 
associated with telephone-based samples, eroding rates of response to single methods of 
contact, and improvements in the databases of household addresses available to researchers. 
Specifically, the Computerized Delivery Sequence File (CDSF) of the US Postal Service, 
the most complete address database available in the US providing near perfect coverage, 
was used as the frame to select a representative sample of household addresses. In order to 
identify enough minority households with a member with epilepsy, a stratified sampling 
design was used whereby DC households in certain Census Block Groups (CBG) were over-
sampled according to the allocation summarized in Table 1.
Survey Design and Administration
There were three phases of data collection for the DCHS, involving four data collection 
instruments. In Phase I a one-page bi-lingual screening survey asked five basic demographic 
and three epilepsy screening questions for all household members. Demographic data 
included age, gender, race/ethnicity, education, and length of residency in DC. Answer 
choices for race/ethnicity included White, Black, Hispanic, Asian, and Other. The epilepsy 
screening questions were derived from the Behavioral Risk Factor Surveillance System’s 
(BRFSS) epilepsy module (Kobau et al., 2008) and included “Ever diagnosed with epilepsy 
or a seizure disorder?”, “Currently taking any medication to control seizures?”, and “What 
year was the first seizure?”. Limited space on the survey did not allow for a question about 
the date of the most recent seizure.
In Phase II, a case survey was mailed to each household that had identified a prevalent case 
of epilepsy from the first screening question in the Phase I survey. The case survey included 
detailed questions about seizures and treatment, co-morbid conditions, quality of life, and 
social factors such as marital status, school and employment. Parents were asked to 
complete the case surveys on behalf of children. Also in Phase II was a control survey which 
was mailed to households that completed a screening survey and reported no prevalent 
cases. The control survey was identical to the case survey without the questions about 
seizures and treatment.
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The Phase III survey was developed after preliminary analyses of the case survey suggested 
that the number of prevalent cases of epilepsy from the screening survey was overestimated 
due to self-reporting of febrile, provoked, and isolated unprovoked seizures. This 
supplemental survey was sent to all cases and included two pages of questions about the 
causes of the seizures.
The surveys and letters of invitation, which included a statement of informed consent, were 
approved by the institutional review board for protection of human subjects at RTI 
International, Research Triangle Park, NC.
Multi-Mode Data Collection
In order to increase response rates, data were collected using several modes of 
administration: mail, telephone, and internet. In June 2008, sample households were initially 
mailed a postcard announcing the upcoming screening survey mailing and the study sponsor 
and local supporters. One week later, households were mailed the Phase I screening survey 
and asked to complete and return it using the postage-paid envelope enclosed. All mailings 
were addressed to the name associated with the household telephone number, when 
available, followed by “or current resident”. A $1 bill was included in the mailing to 
encourage response. The survey was re-sent to all non-responding households without a 
corresponding telephone number approximately 6 weeks after the initial screening survey 
was mailed. At this point, an incentive of $5 was provided for each completed survey. Non-
responding households with a corresponding telephone number, including those for which 
the screener was returned as undeliverable, were called by a trained interviewer beginning 
seven weeks after the initial survey was mailed. If multiple attempts to reach these 
households by telephone were unsuccessful, all non-responding households were re-mailed 
the screening survey. Figure 1 presents the data collection scheme for the screening survey.
Throughout Phase I data collection, any household identified as having an individual with 
epilepsy or a seizure disorder was sent the Phase II case survey to be completed by, or on 
behalf of, the person with seizures. An incentive of $40 was provided for each completed 
case survey. At least one additional attempt was made to contact by mail or telephone each 
non-respondent to the Phase II case survey. Additionally, online versions of Phase I and 
Phase II surveys were available for completion through the study website. Moreover, 
households and cases were invited to call a toll-free number if they preferred to complete the 
surveys by telephone. Data collection for both the screening and case surveys ended in 
January 2009.
In August 2009, the Phase II control survey was administered as a mail-only survey, with 
one mail follow-up of non-respondents six weeks later. The Phase III supplemental survey 
was mailed only once in February 2011 to the initial prevalent cases identified from the 
screening survey, regardless of whether a case survey was already completed. 
Communication with respondents was through household address and not name, so there 
was no way of verifying whether the household members that completed the initial 
screening survey were the same as those that completed the control and supplemental 
surveys. A change in residents for the control survey was not a concern. Effects on the Phase 
III supplemental survey are discussed in the results section.
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Case Definition and Validation
In order to compare the findings from the DCHS with other population-based estimates of 
epilepsy, such as the BRFSS (http://www.cdc.gov/brfss), the results from the Phase I 
screening survey were summarized without influence from the Phase II and III case and 
supplemental surveys. For the Phase I analyses of screened cases, a lifetime prevalent case 
of epilepsy was defined as a positive response to the first screening question about a 
diagnosis of epilepsy or a seizure disorder. For the Phase II/III analyses (the verified cases), 
an epileptologist (WDG) reviewed all case and supplemental surveys and assigned a final 
status of positive or negative for each of the lifetime prevalent cases from the screening 
survey. Epilepsy was confirmed in cases with evidence of two or more unprovoked seizures, 
consistent with the International League Against Epilepsy (ILAE) case definition 
(Commission on Epidemiology and Prognosis of the ILAE, 1993). In addition, missing or 
obvious discrepant data on the Phase I screening survey were replaced with data from the 
Phase II case survey, when available. All survey weights were then adjusted to reflect the 
fact that a subset for which no validation data were available could emerge as false positive 
cases.
An active case of epilepsy was defined as a lifetime prevalent case currently taking a 
medication to control seizures, according to the screening survey. This definition differs 
slightly from that used in the BRFSS and Healthstyles surveys where active epilepsy also 
included a seizure within the previous three months in individuals not taking an anti-
epileptic drug (AED) (Kobau et al 2006, Kobau et al. 2008). Annual incidence of epilepsy 
was calculated from the mean annual number of lifetime prevalent cases with a first seizure 
during the three-year period 2005–2007 based on the screening survey.
Imputation, Weighting and Statistical Analysis
Virtually all survey data are weighted before they can be used to produce reliable estimates 
of population parameters. For this study survey weights were calculated in several steps. In 
the first step, design weights were constructed to reflect different selection probabilities used 
to oversample households in certain block groups based on household income and percent 
Black race. These weights were adjusted to account for unknown eligibility and differential 
non-response, while the resulting weights were then post-stratified to reported counts of DC 
households indexed by characteristics such as household size. In addition to these 
household-level weights, a second set of person-level weights were calculated by reflecting 
the number of household members and post-stratification of the resulting weights to match 
weighted distributions of DC residents with respect to gender, race, and age from the 2009 
Current Population Survey (March Supplement, http://www.census.gov/cps/). Depending on 
the level at which survey estimates were produced (household or person) the corresponding 
set of weights were applied.
Missing values for all variables were first imputed using a sequential hot-deck technique 
(Kalton & Kasprzakand, 1986). Specifically, missing values were replaced in a random 
fashion so that their corresponding observed distributions would be retained for the 
combined data. This process was implemented by first imputing the variable with the 
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smallest number of missing values (gender) followed by the imputation of other variables, 
such as age, race, and education.
Subsequently, all estimations and analyses were carried out using weighted data and 
appropriate survey procedures in SAS to reflect the resulting weights and design features 
employed to select sample households (http://support.sas.com/rnd/app/da/new/
dasurvey.html). Such procedures, including SurveyMeans and SurveyLogistic rely on Taylor 
Linearization technique to approximate variances of weighted survey estimates.
RESULTS
Response Rates
There were 6,447 households, representing 12,894 individuals (10,753 adults, 2,141 
children), that responded to the DCHS screening survey for an overall unadjusted response 
rate of 32.2%. After adjustment for returned vacancies and undeliverable mail, the response 
rate increased to 36.6%. The mode of response to the completed surveys included 78.4% by 
mail, 13.4% by telephone, and 8.2% by web (Figure 1).
The demographic composition of the individuals in the study is presented in Table 2. There 
were more females (55.6%) than males (44.4%) and more Blacks (48.3%) than Whites 
(40.2%). Almost 54% of the study population was between the ages of 18 and 54 and 12.5% 
had recently moved into the DC city limits. There were 208 cases of epilepsy (174 adults, 34 
children) reported by the screening survey in 201 households. Over half of the cases (115, 
55%) were identified from responses to the first mailing, but the proportion of households 
with cases among the responders was higher for the subsequent mailings (Figure 1).
Respondents to the Phase II case survey included 122 (58.7%) of the individuals identified 
as epilepsy cases on the screening survey (105 adults, 17 children). Those that returned a 
case survey compared to those that did not were more likely to be White (30.9% versus 
11.8%), female (54.5% versus 47.6%), have post high school education (59.7% versus 
37.8%), have lived in DC for three years or less (75.6% versus 54.8%), and be taking an 
AED (53.7% versus 45.9%). Sixty-three (30.3%) of 208 Phase III surveys were returned. 
Phase II control surveys mailed to 4,994 adults and 1,244 adult-child pairs were completed 
for 35.9% children and 35.5% adults. Findings from the case and control surveys will be the 
subject of a separate report.
Case validation
For the analyses of verified cases, 141 (67.8%) of the 208 cases from the Phase I screening 
survey had at least one Phase II or Phase III survey for review of their epilepsy status. 
However, 16 of 63 (25.4%) Phase III surveys reported no evidence of seizures in a 
household member and 15 of these 16 reported no recollection of previously being in the 
study. These 16 surveys were excluded from further consideration of epilepsy status because 
of the likelihood that the household residents had changed since the screening survey was 
completed three years prior. This left 133 of 208 (63.9%) screened cases with at least one 
Phase II or III survey for review. Of these 133, 112 (84.2%) were given a final case status of 
positive and 21 (14 adults and 7 children) were re-assigned as a non-case. Reasons for the 
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reassignment included febrile seizures only (28.6%), provoked only (42.9%), single 
unprovoked (14.3%), and a single seizure of unknown cause (14.3%).
Three people (14.3%) classified as a non-case, including two older than 80 years of age, 
reported currently taking an AED on the screening survey. In comparison, 58 of the 112 
verified cases (51.8%) reported currently taking an AED on the screening survey.
Prevalence of Lifetime and Active Epilepsy
The weighted lifetime prevalence of self-reported epilepsy in DC was 1.78% [95% CI 1.52–
2.05] for the screened cases (Table 2). After restricting the analysis to verified cases, the 
prevalence of lifetime epilepsy declined to 1.53% [1.28–1.77]. With this adjustment, 
lifetime prevalence was highest in those 55–69 years of age (1.85% [1.24–2.46]) compared 
to the other age groups (range 1.25–1.53%) although none of the differences were 
significant. There was also no appreciable difference in prevalence by gender. In contrast, 
Blacks had nearly a three-fold higher prevalence (2.13% [1.73–2.53]) than Whites (0.77% 
[0.52–1.03]) and over twice the prevalence of those of Hispanic origin (0.95% [0.22–1.68]). 
Lifetime prevalence of epilepsy was inversely associated with the highest level of education 
in adults and ranged from 3.40% [1.87–4.92] for those with less than a high school 
education to 0.69% [0.41–0.96] for those that attended graduate school. Although the 
categories for annual household income spanned just $20,000 from highest to lowest, 
income was also inversely associated with lifetime prevalence of epilepsy in adults. The 
prevalence was significantly higher for those with income less than $30,000 (2.27% [1.72–
2.83]) compared to those with income of $30,000-$49,000 (1.26% [0.89–1.63]) and greater 
than $49,000 (1.06% [0.77–1.35]). Length of residency in DC was also significantly 
associated with epilepsy prevalence. Adults that recently relocated into the city had a 
lifetime prevalence of epilepsy that was almost a third (0.65% [0.22–1.08]) of that found in 
residents living in DC for more than three years (1.80% [1.47–2.13]).
Prevalence of active epilepsy followed the same trends among subgroups as lifetime 
prevalence and overall was 0.86% [0.67–1.05] for screened cases and 0.79% [0.62–0.97] for 
verified cases (Table 2). In verified analyses, active epilepsy was highest in Blacks (1.13% 
[0.84–1.42]) compared to Whites (0.33% [0.17–0.49], individuals age 55–69 years of age 
(1.25% [0.74–1.75]) compared to other ages (range 0.55–0.95%), those with annual 
household incomes less than $30,000 (1.12% [0.73–1.51]) compared to greater income 
levels, those with less than a high school diploma (2.46% [1.19–3.72]) compared to high 
school graduates (1.31% [0.72–1.91]) or attendees of college (0.80% [0.48–1.11]) or 
graduate school (0.38% [0.17–0.58]). Adults living in DC for more than 3 years had a 
prevalence of active epilepsy that was three times greater (0.99% [0.75–1.23]) than those 
that had more recently moved into the city (0.32% [0.04–0.61]).
Cohabitation was another factor related to lifetime (p<.001) and active (p=.05) epilepsy 
status. Of adults with a history of epilepsy from weighted data, 31.6% lived alone and 68.4% 
shared a dwelling. In comparison, 46.7% of the non-epilepsy households were single 
occupancy. Adults with active epilepsy were also less likely to live alone than those without 
epilepsy (36.0% versus 46.1%).
Kroner et al. Page 7













Results for age-adjusted lifetime and active epilepsy from multivariate analyses using the 
verified cases dataset are presented in Table 3. Independent of age, education and income, 
Blacks had a lifetime prevalence rate (PR) that was 1.74 higher [1.08–2.82] than Whites and 
an active epilepsy PR that was 2.05 higher [1.05–3.98] than Whites. Those of Other race 
were at lower risk compared to Whites (PR 0.75 [0.33–1.69] for lifetime prevalence and PR 
0.64 [0.20–2.00] for active prevalence), however these rates were not significantly different 
from 1.0. Education was also independently associated with epilepsy prevalence in adults 
after adjusting for age, income and race/ethnicity. Compared to those that attended graduate 
school, adults with less than a high school diploma had a significantly higher PR of lifetime 
epilepsy (3.92 [1.93 – 7.96]) and of active epilepsy (4.61 [1.84–11.55]). PRs for lifetime and 
active epilepsy for other levels of education compared to graduate school included 2.33 
[1.24–4.36] and 2.04 [0.89–4.69, respectively, for high school diploma and 2.01 [1.23–3.28] 
and 1.64 [0.80–3.36], respectively, for college.
Incidence of Epilepsy
There were 23 cases of epilepsy (15 adults, 8 children) with a year of first seizure between 
2005 and 2007 that were weighted and included in the incidence estimates. Overall, the 
annual incidence per 100,000 persons was 75 [41–110] and was similar for males and 
females. Incidence for all children was more than twice that for adults (140 compared to 60). 
The incidence rate by age group was highest in children less than four years of age (430 
[52–807]) and then declined to 49–50 per 100,000 until 55 years of age. The incidence 
reached a second peak between 55–69 years (115 [18–211]) and then fell sharply to 19 [0–
57] in those 70 years of age and older. The incidence rate for Blacks was 109 [49–169] 
which was more than three times that for Whites (34 [6–62]). Unlike results for epilepsy 
prevalence, the incidence was higher among those of Other non-Hispanic race (80 [0–235]) 
compared to Hispanics (26 [0–76]) although the weighted numbers of new cases in these 
subgroups were small (18 and 13, respectively).
DISCUSSION
This is the first study to our knowledge that has demonstrated a significant association 
between epilepsy, race, and socioeconomic indicators in multivariate analysis. Blacks had a 
PR for lifetime epilepsy that was 1.74 times higher than that of Whites after adjusting for 
age, education and income, and a corresponding PR for active epilepsy that was twice that 
for Whites. Adults with less than a high school education had a PR for lifetime and active 
epilepsy that was 4 times higher than those with an advanced degree, independent of age, 
race, ethnicity, and income.
The higher risk of epilepsy in Blacks may be related to environmental factors, quality of 
health care, cultural knowledge and beliefs, or other confounding factors that are related to 
both self-reported epilepsy and race. People of Hispanic origin prefer the word “attacks” to 
epilepsy or seizures (Sirven et al.,2005). There may be other racial or ethnic preferences that 
influence self-identification with the clinical term epilepsy among minorities and 
immigrants and how they respond to a survey about epilepsy. Sorting out potential barriers 
to accurate survey responses in these populations requires further study.
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Similar to most cross-sectional studies (Banerjee & Hauser, 2008), we did not see a steady 
increase in lifetime prevalence with age, with a peak at 55–69 years. The subsequent decline 
in prevalence in the elderly in our study may have been the result of unrecognized epileptic 
seizures, reduced survival among people with epilepsy, an incomplete medical history of 
childhood onset seizures passed from the parents, or recall bias, particularly of a distant 
history of epilepsy in childhood.
We demonstrated an over-reporting of lifetime prevalence of epilepsy among residents of 
DC by 16% (1.78 compared to 1.53) after including additional screening questions about 
seizures and treatment. This finding is similar to the 18% over-estimation of epilepsy from 
another population-based study with limited screening (Kelvin et al. 2007). For active 
epilepsy, the over-reporting declined to 9% which was not surprising given that AED use 
defined the condition and was relatively rare in the false positive cases.
Epilepsy was more commonly over-reported in children, the elderly, Hispanics, under-
educated adults, and adults that were new residents to DC in our study. During the validation 
process, febrile seizures were easy to identify but provoked seizures were sometimes harder 
to distinguish from remote symptomatic seizures based on the limited number of questions 
and the responses that were provided. Nine of 21 (42.8%) false positive cases had provoked 
seizures while 42 of 101 (41.6%) verified cases had remote symptomatic seizures. Trauma 
accounted for 26% of the epilepsy in adults in DC compared to less than 9% reported in a 
meta-analysis of over thirty studies (Banerjee & Hauser, 2008). Classifying acute and 
remote symptomatic seizures as epilepsy or not in a population-based study may be 
challenging without support from accompanying medical records or targeted interview data.
The overall incidence of epilepsy (71 per 100,000) was higher than that found in other US 
populations but similar or lower than that reported in some African countries (WHO, 2004). 
Within racial subgroups, incidence was highest among Blacks. Similar to other studies, we 
found peaks in incidence of epilepsy in the youngest age group (0–3 years of age) and in the 
older middle age group (55–69 years of age). The incidence was very low (19 per 100,000) 
in elderly DC residents which may be related to unrecognized epileptic seizures or survival 
bias. The life expectancy of 74 years for DC residents is the lowest of all 50 States.
The lower prevalence and incidence of epilepsy in new residents of DC probably represents 
a “healthy mover” effect where individuals without chronic health problems are more likely 
to relocate to start a new job or attend higher education and be less concerned about 
maintaining consistency in medical providers than those with chronic disease. The Hispanic 
population in DC has nearly doubled in the past decade and this ability to immigrate may 
account for the lower rates of epilepsy in the Hispanic population in our study.
In one respect, it was reassuring to find that adults with active epilepsy were significantly 
less likely to live alone than the general adult population in DC and that at least one other 
household member may be available to provide assistance in the event of a serious seizure. 
On the other hand, sharing a dwelling may also indicate that some adults with epilepsy in 
DC are more likely to need assistance with their daily living activities than those without 
epilepsy. Lower neurocognitive functioning and lower educational achievement are well 
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documented outcomes of childhood onset epilepsy, even in those without remote 
symptomatic causes (Shinnar & Pellock, 2002, Sillanpaa, 1990, Fastenau et al., 2008; Geerts 
et al., 2011, Berg et al., 2011), and these factors can also influence independent living. Two 
prospective studies found that adults with childhood onset epilepsy were more likely to live 
with a family member than a life partner or independently (Sillanpaa, 1990; Geerts et al., 
2011). Further research is needed to address the full impact of epilepsy on caregivers and on 
the quality of care received by dependent adults with epilepsy. This research should extend 
to families of children with epilepsy to identify areas for early intervention in impaired 
family functioning (Duffy, 2011).
There are several limitations to our study that should be noted, the primary one being the 
low response rate. An address-based sampling methodology was employed to give all 
households in DC an equal chance of selection by administering the survey using several 
modes of data collection, as well as incentives, to increase response rates. In spite of this, the 
rate of response to our survey was lower than desired (37%) but not different from that 
found in other population-based surveys. Biener et al. (2004) and Curtin et al. (2005) note 
that the rate of response to general public surveys has been on a steady decline. More recent 
investigations by Fahimi et al. (2008) reveal that response rates to well-founded government 
surveys, such as the BRFSS, follow this trend as well. We took steps to reduce as much of 
the potential non-response bias as possible by further adjusting the non-response-adjusted 
weights to match the demographic composition of the DC households.
A low response rate may have resulted in non-random bias regarding the epilepsy status of 
household members that returned the screening survey compared to those that did not. 
Unlike the BRFSS, sample households were aware of the nature of our study after the first 
contact was made. Households that had a member with a history of epilepsy may have been 
more likely (or less likely due to stigma) to complete the survey than households without a 
history of epilepsy.
Our definition of active epilepsy differed from the BRFSS in that we were not able to 
include occurrence of a seizure in the previous three months in those not taking an AED, 
which has been estimated to be 7% of active cases (Kobau et al., 2008). However, in our 
analysis of verified cases, this difference in definition would tend to be off-set by exclusion 
of false positive cases that were taking an AED which we found to be 14%.
Another limitation of the study includes the proxy reporting of information about most of 
the household members. The data collected for all individuals living in a household was 
presumably provided by one person who completed the screening survey. This person may 
not have been familiar with the complete health history of other household members. This 
limitation would cause an underestimate of the lifetime prevalence of epilepsy, particularly 
of resolved childhood onset.
Nonetheless, our results are well within the range of prevalence estimates reported by others. 
Furthermore, our study is the first to provide region-specific estimates and profiles of the 
epilepsy population in DC which can help inform policy makers and healthcare providers on 
where to better target resources to improve the health and outcomes of people with epilepsy 
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and their families. Subsequently, we have initiated a large clinical cohort study of DC 
children with epilepsy and their families to address pediatric and parental co-morbidities and 
the effects of family functioning on access to quality medical care in a vulnerable 
population.
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Table 3
Age-adjusted Predictors of Lifetime and Active Epilepsy in Multivariate Analyses1
Lifetime Epilepsy Active Epilepsy
Odds Ratio (95% CI) Odds Ratio (95% CI)
Race
  Black 1.74 (1.08 – 2.82) 2.05 (1.05 – 3.98)
  Other2 0.75 (0.33 – 1.69) 0.64 (0.20 – 2.00)
  White 1.0 1.0
Highest Education
  Less than high school diploma 3.92 (1.93 – 7.96) 4.61 (1.84 – 11.55)
  High school graduate 2.33 (1.24 – 4.36) 2.04 (0.89 – 4.69)
  College 2.01 (1.23 – 3.28) 1.64 (0.80 – 3.36)
  Graduate school 1.0 1.0
Annual Household Income
  Less than $30,000 1.39 (0.94 – 2.05) 1.33 (0.80 – 2.18)
  $30,000 of more 1.0 1.0
1
Adults over 24 years of age using the verified dataset
2
Other race = other than non-Hispanic Black and non-Hispanic White























Overall 12,741 75 (41–110) 71 (39–103)
Gender
  Male 5,649 74 (23–124) 69 (21–116)
  Female 7,092 77 (30–124) 73 (29–116)
Children/Adults
  0–17 years 2,142 140 (32–248) 135 (29–240)
  >17 years 10,599 60 (28–92) 55 (26–84)
Age Group
  0–3 years 517 430 (52–807) 408 (43–773)
  4–17 years 1,625 49 (0–127) 49 (0–127)
  18–54 years 6,821 50 (14–86) 46 (13–78)
  55–69 years 2,386 115 (18–211) 105 (17–194)
  More than 69 years 1,392 19 (0–57) 19 (0–57)
Race/Ethnicity
  White 5,138 34 (6–62) 33 (6–60)
  Black 6,123 109 (49–169) 102 (46–158)
  Hispanic 779 26 (0–76) 22 (0–65)
  Other 701 80 (0–235) 68 (0–201)
Highest Education2
  Less than high school diploma 601 76 (0–226) 76 (0–226)
  High school graduate/equivalency 1,525 89 (0–189) 84 (0–179)
  College 3,756 89 (23–154) 78 (21–134)
  Graduate or professional degree 3,700 21 (0–51) 21 (0–51)
Residence in DC2
  0–3 years 1,600 28 (0–82) 28 (0–82)
  More than 3 years 7,982 71 (31–112) 65 (28–102)
1
Number of unweighted observations without epilepsy prior to 2005
2
Adults over 24 years of age
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